Ghent University Academic Bibliography

Advanced

Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist Nutlin-3

Tom Van Maerken UGent, Ali Rihani UGent, Daniel Dreidax, Sarah De Clercq UGent, Nurten Yigit UGent, Jean-Christophe Marine UGent, Frank Westermann, Anne De Paepe UGent, Jo Vandesompele UGent and Franki Speleman UGent (2011) MOLECULAR CANCER THERAPEUTICS. 10(6). p.983-993
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
P53/MDM2/P14(ARF) PATHWAY, CYTOPLASMIC SEQUESTRATION, ARF TUMOR-SUPPRESSOR, WILD-TYPE P53, INDUCED APOPTOSIS, GENE-MUTATIONS, LINES, FREQUENCY, NUCLEAR, SENSITIZES NEUROBLASTOMA
journal title
MOLECULAR CANCER THERAPEUTICS
Mol. Cancer Ther.
volume
10
issue
6
pages
983 - 993
Web of Science type
Article
Web of Science id
000291428000007
JCR category
ONCOLOGY
JCR impact factor
5.226 (2011)
JCR rank
28/190 (2011)
JCR quartile
1 (2011)
ISSN
1535-7163
DOI
10.1158/1535-7163.MCT-10-1090
project
Bioinformatics: from nucleotids to networks (N2N)
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1860417
handle
http://hdl.handle.net/1854/LU-1860417
date created
2011-07-20 14:08:57
date last changed
2013-02-27 09:10:29
@article{1860417,
  author       = {Van Maerken, Tom and Rihani, Ali and Dreidax, Daniel and De Clercq, Sarah and Yigit, Nurten and Marine, Jean-Christophe and Westermann, Frank and De Paepe, Anne and Vandesompele, Jo and Speleman, Franki},
  issn         = {1535-7163},
  journal      = {MOLECULAR CANCER THERAPEUTICS},
  keyword      = {P53/MDM2/P14(ARF) PATHWAY,CYTOPLASMIC SEQUESTRATION,ARF TUMOR-SUPPRESSOR,WILD-TYPE P53,INDUCED APOPTOSIS,GENE-MUTATIONS,LINES,FREQUENCY,NUCLEAR,SENSITIZES NEUROBLASTOMA},
  language     = {eng},
  number       = {6},
  pages        = {983--993},
  title        = {Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist Nutlin-3},
  url          = {http://dx.doi.org/10.1158/1535-7163.MCT-10-1090},
  volume       = {10},
  year         = {2011},
}

Chicago
Van Maerken, Tom, Ali Rihani, Daniel Dreidax, Sarah De Clercq, Nurten Yigit, Jean-Christophe Marine, Frank Westermann, Anne De Paepe, Jo Vandesompele, and Franki Speleman. 2011. “Functional Analysis of the P53 Pathway in Neuroblastoma Cells Using the Small-molecule MDM2 Antagonist Nutlin-3.” Molecular Cancer Therapeutics 10 (6): 983–993.
APA
Van Maerken, T., Rihani, A., Dreidax, D., De Clercq, S., Yigit, N., Marine, J.-C., Westermann, F., et al. (2011). Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist Nutlin-3. MOLECULAR CANCER THERAPEUTICS, 10(6), 983–993.
Vancouver
1.
Van Maerken T, Rihani A, Dreidax D, De Clercq S, Yigit N, Marine J-C, et al. Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist Nutlin-3. MOLECULAR CANCER THERAPEUTICS. 2011;10(6):983–93.
MLA
Van Maerken, Tom, Ali Rihani, Daniel Dreidax, et al. “Functional Analysis of the P53 Pathway in Neuroblastoma Cells Using the Small-molecule MDM2 Antagonist Nutlin-3.” MOLECULAR CANCER THERAPEUTICS 10.6 (2011): 983–993. Print.